Skip to content

VanishPoint® 24321Recalls & reported problems

Retractable Technologies, Inc. · 23G x 3/4" w/12" tubing VanishPoint® Blood Collection Set, Without Luer Adapter · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00613703243201), received between May 23, 2019 and May 23, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Retraction Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Retraction Problem1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 23, 2019Retraction Problem

    WHILE USING A VANISHPOINT 23G ON A PATIENT, I CLICKED THE BUTTON AND THE NEEDLE RETRACTED ONLY HALF WAY STOPPED AND THEN 3 SECONDS LATER RETRACTED ALL THE WAY. THIS IS VERY UNSAFE. MANUFACTURER RESPONSE FOR SET, ADMINISTRATION, INTRAVASCULAR, VANISHPOINT (PER SITE REPORTER). MFR SENT CLINICAL REP ALONG WITH TERRITORY MANAGER, WILL BE SENDING TRAINERS NEXT WEEK.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8635471 ↗

Other Set, Administration, Intravascular devices

All Set, Administration, Intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page